May 16, 2019
EY Announces David Kelleher and Ed Tourtellotte of 4G Clinical as Entrepreneur Of The Year® 2019 Award Finalists in New England
May 16, 2019Kelleher and Tourtellotte join ranks of unstoppable entrepreneurs in New England
WELLESLEY, Ma., May 16, 2019 / PR Newswire/ – EY announced that David Kelleher and Ed Tourtellotte, co-founders of 4G Clinical, are finalists for the Entrepreneur Of The Year® 2019 Award in the New England region.
Widely considered one of the most prestigious business awards programs in the U.S., the program recognizes entrepreneurs and leaders of high-growth companies who are excelling in areas such as innovation, financial performance and personal commitment to their businesses and communities, while also transforming our world. David Kelleher and Ed Tourtellotte were selected as finalists by a panel of independent judges. Award winners will be announced at a special gala event on June 26 at the Westin Waterfront in Boston, Massachusetts.
Kelleher and Tourtellotte founded 4G Clinical, a cutting-edge randomization and trial supply management (RTSM) company in 2015 to bring crucial medicines to those who need them, faster.
|“It is an absolute honor to be named a finalist for this distinguished award,” says Ed Tourtellotte, CTO of 4G Clinical. “Bonded by personal obstacles and our mutual dedication to our purpose, we work together to keep things in perspective and overcome anything that gets in our way. The focus is and continues to be doing our part to disrupt clinical trials and impact the lives of patients.”|
Now in its 33rd year, the program has expanded to recognize business leaders in more than 145 cities and more than 60 countries throughout the world.
Regional award winners are eligible for consideration for the Entrepreneur Of The Year National competition. Award winners in several national categories, as well as the Entrepreneur Of The Year National Overall Award winner, will be announced at the Entrepreneur Of The Year National Awards gala in Palm Springs, California, on November 16, 2019. The awards are the culminating event of the Strategic Growth Forum®, the nation’s most prestigious gathering of high-growth, market-leading companies.
Founded and produced by Ernst & Young LLP, the Entrepreneur Of The Year Awards are nationally sponsored by SAP America and the Ewing Marion Kauffman Foundation.
In the New England region, gold sponsors include fama PR, the Isenberg School of Management at the University of Massachusetts Amherst, Nixon Peabody, True Search and Woodruff Sawyer. Silver sponsors include Brown Brothers Harriman, Chatham Financial, Empire Valuation Consultants, Morgan Lewis, Sullivan & Worcester and T3 Advisors.
About 4G Clinical
4G Clinical is a leader in randomization and trial supply management (RTSM) for the global life sciences industry, offering the only fully cloud-based, 100% configurable and flexible solution utilizing natural language processing (NLP) and integrated supply forecasting. 4G Clinical is headquartered in the Boston Biotech corridor of Wellesley, MA, with offices in Europe and Asia. Learn more about 4G Clinical at www.4gclinical.com.
About Entrepreneur Of The Year®
Entrepreneur Of The Year®, founded by EY, is the world’s most prestigious business awards program for entrepreneurs. The program makes a difference through the way it encourages entrepreneurial activity among those with potential and recognizes the contribution of people who inspire others with their vision, leadership and achievement. As the first and only truly global awards program of its kind, Entrepreneur Of The Year celebrates those who are building and leading successful, growing and dynamic businesses, recognizing them through regional, national and global awards programs in more than 145 cities and more than 60 countries. ey.com/eoy
About EY’s Growth Markets Network
EY’s worldwide Growth Markets Network is dedicated to serving the changing needs of high-growth companies. For more than 30 years, we’ve helped many of the world’s most dynamic and ambitious companies grow into market leaders. Whether working with international mid-cap companies or early stage, venture-backed businesses, our professionals draw upon their extensive experience, insight and global resources to help your business succeed. For more information, please visit us at ey.com/gm or follow news on Twitter @EY_Growth.
EY is a global leader in assurance, tax, transaction and advisory services. The insights and quality services we deliver help build trust and confidence in the capital markets and in economies the world over. We develop outstanding leaders who team to deliver on our promises to all of our stakeholders. In so doing, we play a critical role in building a better working world for our people, for our clients and for our communities.
EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. Information about how EY collects and uses personal data and a description of the rights individuals have under data protection legislation is available via ey.com/privacy. For more information about our organization, please visit ey.com.
This news release has been issued by Ernst & Young LLP, a member of the global EY organization that provides services to clients in the US.
For more information, please visit ey.com.
Tag(s): Press Releases
Amy Ripston, 4G Clinical Vice President of Marketing, has over 20 years of B2B experience, of which she spent 9 years in the bio/pharmaceutical industry. Amy has a knack for identifying market trends, synthesizing content, engaging thought leaders, and connecting businesses with innovative solutions.
Related Blog Posts HeadlineView All Blog Posts
June 1, 2018
4G Clinical Adds Industry Veterans and Launches Tokyo Office: Boosts Global Expansion in Key MarketsRead More
January 30, 2019
EPS Corporation Selects 4G Clinical as IRT/RTSM Provider for Multinational Clinical TrialsRead More
October 22, 2019